The British journal of ophthalmology۲۰۲۶مرور۷ استنادنمایه شده در PubMed
Devesh Kumawat, Sindhuja Kandasamy, Parijat Chandra
چکیده
Anti-vascular endothelial growth factor (anti-VEGF) agents have demonstrated efficacy and short-term safety in the treatment of retinopathy of prematurity (ROP), establishing them as the preferred option for zone I and zone II posterior disease. Despite their advantages, the effects of anti-VEGF…
متن کامل چکیده در سایت ناشر در دسترس است.
DOI: 10.1136/bjo-2025-327597